| Evidence-based approach to acute exacerbations of COPD FJ Soto, B Varkey Current opinion in pulmonary medicine 9 (2), 117-124, 2003 | 118 | 2003 |
| Selective phosphodiesterase-4 inhibitors in chronic obstructive lung disease FJ Soto, NA Hanania Current opinion in pulmonary medicine 11 (2), 129-134, 2005 | 76 | 2005 |
| Bronchoscopic lung volume reduction J Flandes, FJ Soto, R Cordovilla, E Cases, J Alfayate Clinics in Chest Medicine 39 (1), 169-180, 2018 | 20 | 2018 |
| Safety and efficacy of bosentan in combination with sildenafil in PAH patients who experience inadequate clinical response to monotherapy: the COMPASS-3 study RL Benza, H Gupta, FJ Soto, MH Park, F Torres, N Frey, S Murali Chest 138 (4), 840A, 2010 | 20 | 2010 |
| Performance of pulmonary capillary wedge pressure (PCWP) vs. left ventricular end diastolic pressure (LVEDP) in the diagnosis/classification of patients with suspect pulmonary … FJ Soto, R Siegel, D Marks, J Kleczka, T Woods, JP Maloney, A Syed, ... Chest 128 (4), 137S, 2005 | 11 | 2005 |
| Cardiopulmonary hemodynamics in pulmonary hypertension: pressure tracings, waveforms, and more FJ Soto, JF Kleczka Advances in pulmonary hypertension 7 (4), 386-393, 2008 | 10 | 2008 |
| All that wheezes is not asthma: diagnosing the mimics FJ Soto, KK Guntupalli EMERGENCY MEDICINE-NEW YORK-, 40-58, 2001 | 7 | 2001 |
| Utilization of risk assessment tools in management of PAH: A PAH provider survey S Sahay, V Balasubramanian, H Memon, A Poms, E Bossone, K Highland, ... Pulmonary Circulation 12 (2), e12057, 2022 | 5 | 2022 |
| Goal-directed combination therapy in pulmonary arterial hypertension (PAH): Study design of COMPASS-3 F Torres, H Gupta, S Murali, MH Park, FJ Soto, C McQueen, RL Benza Chest 132 (4), 633A, 2007 | 4 | 2007 |
| Achieving clinical thresholds of benefit with bosentan based treatment: the COMPASS-3 trial RL Benza, H Gupta, S Murali, M Park, FJ Soto, F Torres C63. MANAGEMENT OF PULMONARY HYPERTENSION, A4780-A4780, 2012 | 3 | 2012 |
| Safety and efficacy of bosentan in combination with sildenafil in pulmonary arterial hypertension: The COMPASS-3 study F Torres, H Gupta, F Soto, M Park, N Frey, S Murali, R Benza European Respiratory Journal 38 (Suppl 55), 2011 | 3 | 2011 |
| Clinical worsening of pulmonary arterial hypertension: the COMPASS-3 Study RL Benza, H Gupta, F Soto, MH Park, F Torres, N Frey, S Murali B16. PULMONARY ARTERIAL HYPERTENSION: FROM ASSESSING RISK TO THERAPEUTIC …, 2010 | 3 | 2010 |
| Pulmonary venous hypertension: A diagnostic and therapeutic dilemma FJ Soto Advances in Pulmonary Hypertension 6 (4), 168-175, 2007 | 3 | 2007 |
| Pulmonary Venous Hypertension: A Pulmonologist's Perspective F Soto Advances in Pulmonary Hypertension 10 (1), 18-23, 2011 | 2 | 2011 |
| Safety and tolerance of a rapid 3-5 day in-hospital up-titration protocol of subcutaneous (SQ) treprostinil in patients with severe pulmonary arterial hypertension (PAH) FJ Soto Chest 132 (4), 634A, 2007 | 2 | 2007 |
| Longer time interval between infusion site changes for subcutaneous (SQ) treprostinil (Remodulin) in patients with pulmonary hypertension (PH): tolerance and safety FJ Soto, S Girotra, H Cain Am J Respir Crit Care Med 175, A401, 2007 | 2 | 2007 |
| CLINICAL AND HEMODYNAMIC IMPACT OF SUBCUTANEOUS (SQ) TREPROSTINIL (REMODULIN®) IN THE MANAGEMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH): SINGLE-CENTER EXPERIENCE FJ Soto, P Jain, J Kleczka, R Siegel, T Woods, D Marks, K Presberg Chest 130 (4), 120S, 2006 | 2 | 2006 |
| Single center experience with rapid dose escalation of sub-cutaneous (SQ) treprostinil for the treatment of pulmonary arterial hypertension FJ Soto, T Derksen, J Janusz Pulmonary Hypertension Association 7th International PH Conference …, 2006 | 2 | 2006 |
| Clinical and hemodynamic impact of SQ Treprostinil (Remodulin®) in the management of PAH: Single-center experience FJ Soto, P Jain, J Kleczka, R Siegel, T Woods, D Marks Chest 130 (4), 120S, 2006 | 2 | 2006 |
| Nitroprusside (NTP) in the assessment of pulmonary hypertension (PH) associated with elevated left ventricular (LV) filling pressures due to diastolic dysfunction ZK Wendy, J Kleczka, D Marks, R Siegel, K Presberg, T Woods, ... Chest 128 (4), 138S, 2005 | 2 | 2005 |
